Page 558 - 先天性心脏病的导管术：从婴幼儿期到成人期

540 先天性心脏病的导管术：从婴幼儿期到成人期

[8] Delaney JW, et al. Covered CP stent for treatment of right ventricular conduit injury

during melody transcatheter pulmonary valve replacement. Circ Cardiovasc Interv.
2018;11(10):e006598.
[9] Nordmeyer J, et al. Risk stratification, systematic classification, and anticipatory man-
agement strategies for stent fracture after percutaneous pulmonary valve implantation.

Circulation. 2007;115(11):1392-7.
[10] McElhinney DB, et al. Stent fracture, valve dysfunction, and right ventricular outflow
tract reintervention after transcatheter pulmonary valve implantation: patient-relat-
ed and procedural risk factors in the US Melody Valve Trial. Circ Cardiovasc Interv.

2011;4(6):602-14.
[11] Lehner A, et al. The risk of infective endocarditis following interventional pulmonary
valve implantation: a meta-analysis. J Cardiol. 2019;74(3):197-205.
[12] Haas NA, et al. The risk of bacterial endocarditis after percutaneous and surgical biolog-

ical pulmonary valve implantation. Int J Cardiol. 2018;268:55-60.
[13] Groning M, et al. Infective endocarditis in right ventricular outflow tract conduits: a reg-
ister-based comparison of homografts, Contegra grafts and Melody transcatheter valves.
Eur J Cardiothorac Surg. 2019;56(1):87-93.

[14] McElhinney DB, et al. Endocarditis after transcatheter pulmonary valve replacement. J
Am Coll Cardiol. 2018;72(22):2717-28.
[15] Abdelghani M, et al. Infective endocarditis after melody valve implantation in the pul-
monary position: a systematic review. J Am Heart Assoc. 2018;7(13):e008163.

[16] Cheatham JP, et al. Clinical and hemodynamic outcomes up to 7 years after transcathe-
ter pulmonary valve replacement in the US melody valve investigational device exemp-
tion trial. Circulation. 2015;131(22):1960-70.